Issue 2/2020
Content (9 Articles)
Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis
Carla Cristina Souza Gomez, Paloma Lopes Francisco Parazzi, Karl Jan Clinckspoor, Renan Marrichi Mauch, Francisco Benedito Teixeira Pessine, Carlos Emilio Levy, Andressa Oliveira Peixoto, Maria Ângela Gonçalves Oliveira Ribeiro, Antônio Fernando Ribeiro, Douglas Conrad, Paul Marquis Quinton, Fernando Augusto Lima Marson, José Dirceu Ribeiro
Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response
Gokhan Demir, Abdullah Ozkaya, Elmas Yuksel, Gurkan Erdogan, Ugur Tunc, Mevlut Celal Ocal, Yasin Sakır Goker
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
Qiao Liu, Xia Luo, Liubao Peng, Lidan Yi, Xiaomin Wan, Xiaohui Zeng, Chongqing Tan
Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain
Zhu Luo, Jia Miao, Shiqing Shu, Ying Wang, Xiaohong Zhu, Chao Hu, Yali Shen
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function
Daisuke Miyatake, Tomohisa Shibata, Mai Shibata, Yuichiro Kaneko, Kazuo Oda, Tetsuya Nishimura, Masataka Katashima, Hisakuni Sekino, Kenichi Furihata, Akinori Urae
A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting
Yun Bao, Gang Zhao, Shuli Qu, Tengbin Xiong, Xingxing Yao, Bin Wu
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study
Carlo Piccinni, Ippazio Cosimo Antonazzo, Aldo P. Maggioni, Antonella Pedrini, Silvia Calabria, Giulia Ronconi, Letizia Dondi, Nello Martini, Giuseppe Roberto, Tiziana Sampietro, Francesco Sbrana, Beatrice Dal Pino, Federico Bigazzi, Giuseppa Lo Surdo, Elisabetta Volpi, Stefania Biagini, Rosa Gini
Cost Effectiveness of Ceritinib and Alectinib Versus Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-small-cell Lung Cancer
Hongchao Li, Lei Lai, Bin Wu
Bleeding Risk of Therapeutic Unfractionated Heparin and Low Molecular Weight Heparin in Patients with Cirrhosis
Katherine L. Summers, Kyle A. Davis, Sarah A. Nisly